Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Papillomavirus Infections × Artesunate × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Intestinal Neoplasms 2 Colorectal Neoplasms 2 Papillomavirus Infections 1 Malaria 1 Lymphoma, Follicular 1 Carcinoma, Hepatocellular 1 CIN 2/3 1 Breast Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 38 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 30 Papillomavirus Vaccines 24 Vaccines 11 Human Papillomavirus Recombinant Vaccine nonavalent 10 Data Collection 9 Colposcopy 9 Blood Specimen Collection 9 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Human Papillomavirus DNA Tests 7 Cisplatin 7 Carboplatin 6 Vaginal Smears 5 Vaccines, Synthetic 5 Educational Status 5 Early Intervention, Educational 5 Surveys and Questionnaires 4 Methods 4 Engerix-B 4 fludarabine 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Polymerase Chain Reaction 3 Paclitaxel 3 Observation 3 Imiquimod 3 Hepatitis A Vaccines 3 Cyclophosphamide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡